Undervalued Stocks Based On Cash Flows

結果

36

10 新しい

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

36 各社

会社概要最終価格7Dリターン1Yリターン時価総額アナリストの目標評価成長配当利回り産業
9660
新しい
HK$4.757.5%-31.5%HK$69.2bHK$10.6915.975.0%n/aSoftware
1651
HK$57.00-12.9%168.2%HK$21.0bHK$65.6916.615.7%3.2%Capital Goods
697
新しい
HK$1.702.4%-7.6%HK$13.8bHK$2.6644.637.3%2.2%Real Estate Management and Development
6185
HK$24.34-0.7%-38.1%HK$9.9bHK$50.324.657.2%0%Pharmaceuticals & Biotech
6990
HK$517.00-3.6%37.9%HK$123.6bHK$563.1051.945.5%n/aPharmaceuticals & Biotech
2315
HK$51.90-11.8%151.3%HK$53.6bHK$62.0369.040.4%n/aPharmaceuticals & Biotech
2268
HK$54.75-12.6%2.1%HK$69.3bHK$83.0940.529.3%n/aPharmaceuticals & Biotech
2589
新しい
HK$99.4010.6%-29.5%HK$10.5bHK$88.3518.014.3%2.3%Consumer Services
6181
HK$397.205.9%-49.5%HK$70.2bHK$823.6812.518.2%7.0%Consumer Durables
9926
HK$98.90-4.4%-31.0%HK$91.1bHK$171.0325.846.5%n/aPharmaceuticals & Biotech
2718
HK$106.30-23.8%n/aHK$15.5bHK$332.019.4145.4%n/aSoftware
1801
HK$92.25-4.9%4.8%HK$160.6bHK$117.50170.532.5%n/aPharmaceuticals & Biotech
1866
新しい
HK$9.0911.7%49.8%HK$13.2bHK$12.8812.225.4%4.1%Materials
1318
HK$57.206.1%-43.4%HK$28.0bHK$98.3420.117.1%2.0%Household
2252
HK$21.82-10.8%17.9%HK$22.5bHK$37.4135.390.9%n/aHealthcare
6656
新しい
HK$294.400.8%n/aHK$73.3bHK$618.8321.732.7%0.9%Capital Goods
1357
HK$4.08-0.7%-61.7%HK$18.6bHK$9.2321.931.3%2.4%Media
1060
HK$0.480%-60.2%HK$14.5bHK$0.9417.820.4%n/aMedia
2698
新しい
HK$31.6016.9%n/aHK$19.6bHK$40.7420.615.2%2.2%Household
2145
HK$28.001.8%-62.7%HK$11.1bHK$86.138.716.7%5.2%Household
2235
HK$7.110.3%12.0%HK$3.0bHK$11.8163.644.9%n/aHealthcare
9658
HK$10.685.2%-33.7%HK$6.9bHK$14.4531.030.5%n/aConsumer Services
3396
HK$13.35-1.8%34.2%HK$31.5bHK$13.5725.644.5%0.9%Tech
3858
HK$55.2012.2%n/aHK$25.2bHK$96.4882.452.4%n/aMaterials
Page 1 of 1